EP3601612 - USE OF ARGININE AS AN ANTICOAGULANT IN THE POLYMERASE CHAIN REACTION [Right-click to bookmark this link] | |||
Former [2020/06] | USE OF ANTICOAGULANTS IN THE POLYMERASE CHAIN REACTION | ||
[2021/25] | Status | No opposition filed within time limit Status updated on 01.07.2022 Database last updated on 19.10.2024 | |
Former | The patent has been granted Status updated on 23.07.2021 | ||
Former | Grant of patent is intended Status updated on 06.06.2021 | ||
Former | Examination is in progress Status updated on 02.10.2020 | ||
Former | Request for examination was made Status updated on 03.01.2020 | ||
Former | The international publication has been made Status updated on 29.09.2018 | ||
Former | unknown Status updated on 10.04.2018 | Most recent event Tooltip | 27.09.2024 | Lapse of the patent in a contracting state New state(s): MT | published on 30.10.2024 [2024/44] | Applicant(s) | For all designated states Genedrive Diagnostics Ltd. The Incubator Building Grafton Street Manchester M13 9XX / GB | [2020/06] | Inventor(s) | 01 /
AINSWORTH, Shaun Incubator Building Grafton Street Manchester Greater Manchester M13 9XX / GB | 02 /
COBB, Ben Incubator Building Grafton Street Manchester Greater Manchester M13 9XX / GB | 03 /
MIELE, Gino Incubator Building Grafton Street Manchester Greater Manchester M13 9XX / GB | [2020/06] | Representative(s) | Williams, Gareth Owen Marks & Clerk LLP 62-68 Hills Road Cambridge CB2 1LA / GB | [2020/06] | Application number, filing date | 18714049.6 | 16.03.2018 | [2020/06] | WO2018GB50683 | Priority number, date | GB20170004401 | 20.03.2017 Original published format: GB 201704401 | [2020/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018172749 | Date: | 27.09.2018 | Language: | EN | [2018/39] | Type: | A1 Application with search report | No.: | EP3601612 | Date: | 05.02.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.09.2018 takes the place of the publication of the European patent application. | [2020/06] | Type: | B1 Patent specification | No.: | EP3601612 | Date: | 25.08.2021 | Language: | EN | [2021/34] | Search report(s) | International search report - published on: | EP | 27.09.2018 | Classification | IPC: | C12Q1/686 | [2020/06] | CPC: |
C12Q1/686 (EP,US);
C12Q1/6806 (EP,US);
C12Q2527/125 (US)
| C-Set: |
C12Q1/6806, C12Q2527/125 (EP);
C12Q1/686, C12Q2527/125 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/06] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | VERWENDUNG VON ARGININ ALS ANTIKOAGULANT IN DER POLYMERASE-KETTENREAKTION | [2021/25] | English: | USE OF ARGININE AS AN ANTICOAGULANT IN THE POLYMERASE CHAIN REACTION | [2021/25] | French: | UTILISATION DE L'ARGININE COMME ANTICOAGULANT DANS LA RÉACTION EN CHAÎNE DE LA POLYMÉRASE | [2021/25] |
Former [2020/06] | VERWENDUNG VON ANTIKOAGULANTIEN IN DER POLYMERASE-KETTENREAKTION | ||
Former [2020/06] | USE OF ANTICOAGULANTS IN THE POLYMERASE CHAIN REACTION | ||
Former [2020/06] | UTILISATION D'ANTICOAGULANTS DANS LA RÉACTION EN CHAÎNE DE LA POLYMÉRASE | Entry into regional phase | 01.07.2019 | National basic fee paid | 01.07.2019 | Designation fee(s) paid | 01.07.2019 | Examination fee paid | Examination procedure | 01.07.2019 | Examination requested [2020/06] | 01.07.2019 | Date on which the examining division has become responsible | 15.04.2020 | Amendment by applicant (claims and/or description) | 06.10.2020 | Despatch of a communication from the examining division (Time limit: M04) | 28.01.2021 | Reply to a communication from the examining division | 07.06.2021 | Communication of intention to grant the patent | 15.07.2021 | Fee for grant paid | 15.07.2021 | Fee for publishing/printing paid | 15.07.2021 | Receipt of the translation of the claim(s) | Opposition(s) | 27.05.2022 | No opposition filed within time limit [2022/31] | Fees paid | Renewal fee | 12.03.2020 | Renewal fee patent year 03 | 12.03.2021 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 16.03.2018 | AL | 25.08.2021 | AT | 25.08.2021 | CY | 25.08.2021 | CZ | 25.08.2021 | DK | 25.08.2021 | EE | 25.08.2021 | ES | 25.08.2021 | FI | 25.08.2021 | HR | 25.08.2021 | IT | 25.08.2021 | LT | 25.08.2021 | LV | 25.08.2021 | MC | 25.08.2021 | MK | 25.08.2021 | MT | 25.08.2021 | NL | 25.08.2021 | PL | 25.08.2021 | RO | 25.08.2021 | RS | 25.08.2021 | SE | 25.08.2021 | SI | 25.08.2021 | SK | 25.08.2021 | SM | 25.08.2021 | BG | 25.11.2021 | NO | 25.11.2021 | GR | 26.11.2021 | IS | 25.12.2021 | PT | 27.12.2021 | IE | 16.03.2022 | LU | 16.03.2022 | BE | 31.03.2022 | CH | 31.03.2022 | LI | 31.03.2022 | [2024/44] |
Former [2024/24] | HU | 16.03.2018 | |
AL | 25.08.2021 | ||
AT | 25.08.2021 | ||
CY | 25.08.2021 | ||
CZ | 25.08.2021 | ||
DK | 25.08.2021 | ||
EE | 25.08.2021 | ||
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
HR | 25.08.2021 | ||
IT | 25.08.2021 | ||
LT | 25.08.2021 | ||
LV | 25.08.2021 | ||
MC | 25.08.2021 | ||
MK | 25.08.2021 | ||
NL | 25.08.2021 | ||
PL | 25.08.2021 | ||
RO | 25.08.2021 | ||
RS | 25.08.2021 | ||
SE | 25.08.2021 | ||
SI | 25.08.2021 | ||
SK | 25.08.2021 | ||
SM | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
GR | 26.11.2021 | ||
IS | 25.12.2021 | ||
PT | 27.12.2021 | ||
IE | 16.03.2022 | ||
LU | 16.03.2022 | ||
BE | 31.03.2022 | ||
CH | 31.03.2022 | ||
LI | 31.03.2022 | ||
Former [2024/23] | AL | 25.08.2021 | |
AT | 25.08.2021 | ||
CY | 25.08.2021 | ||
CZ | 25.08.2021 | ||
DK | 25.08.2021 | ||
EE | 25.08.2021 | ||
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
HR | 25.08.2021 | ||
IT | 25.08.2021 | ||
LT | 25.08.2021 | ||
LV | 25.08.2021 | ||
MC | 25.08.2021 | ||
MK | 25.08.2021 | ||
NL | 25.08.2021 | ||
PL | 25.08.2021 | ||
RO | 25.08.2021 | ||
RS | 25.08.2021 | ||
SE | 25.08.2021 | ||
SI | 25.08.2021 | ||
SK | 25.08.2021 | ||
SM | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
GR | 26.11.2021 | ||
IS | 25.12.2021 | ||
PT | 27.12.2021 | ||
IE | 16.03.2022 | ||
LU | 16.03.2022 | ||
BE | 31.03.2022 | ||
CH | 31.03.2022 | ||
LI | 31.03.2022 | ||
Former [2024/20] | AL | 25.08.2021 | |
AT | 25.08.2021 | ||
CY | 25.08.2021 | ||
CZ | 25.08.2021 | ||
DK | 25.08.2021 | ||
EE | 25.08.2021 | ||
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
HR | 25.08.2021 | ||
IT | 25.08.2021 | ||
LT | 25.08.2021 | ||
LV | 25.08.2021 | ||
MC | 25.08.2021 | ||
NL | 25.08.2021 | ||
PL | 25.08.2021 | ||
RO | 25.08.2021 | ||
RS | 25.08.2021 | ||
SE | 25.08.2021 | ||
SI | 25.08.2021 | ||
SK | 25.08.2021 | ||
SM | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
GR | 26.11.2021 | ||
IS | 25.12.2021 | ||
PT | 27.12.2021 | ||
IE | 16.03.2022 | ||
LU | 16.03.2022 | ||
BE | 31.03.2022 | ||
CH | 31.03.2022 | ||
LI | 31.03.2022 | ||
Former [2023/10] | AL | 25.08.2021 | |
AT | 25.08.2021 | ||
CZ | 25.08.2021 | ||
DK | 25.08.2021 | ||
EE | 25.08.2021 | ||
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
HR | 25.08.2021 | ||
IT | 25.08.2021 | ||
LT | 25.08.2021 | ||
LV | 25.08.2021 | ||
MC | 25.08.2021 | ||
NL | 25.08.2021 | ||
PL | 25.08.2021 | ||
RO | 25.08.2021 | ||
RS | 25.08.2021 | ||
SE | 25.08.2021 | ||
SI | 25.08.2021 | ||
SK | 25.08.2021 | ||
SM | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
GR | 26.11.2021 | ||
IS | 25.12.2021 | ||
PT | 27.12.2021 | ||
IE | 16.03.2022 | ||
LU | 16.03.2022 | ||
BE | 31.03.2022 | ||
CH | 31.03.2022 | ||
LI | 31.03.2022 | ||
Former [2023/09] | AL | 25.08.2021 | |
AT | 25.08.2021 | ||
CZ | 25.08.2021 | ||
DK | 25.08.2021 | ||
EE | 25.08.2021 | ||
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
HR | 25.08.2021 | ||
IT | 25.08.2021 | ||
LT | 25.08.2021 | ||
LV | 25.08.2021 | ||
MC | 25.08.2021 | ||
NL | 25.08.2021 | ||
PL | 25.08.2021 | ||
RO | 25.08.2021 | ||
RS | 25.08.2021 | ||
SE | 25.08.2021 | ||
SI | 25.08.2021 | ||
SK | 25.08.2021 | ||
SM | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
GR | 26.11.2021 | ||
IS | 25.12.2021 | ||
PT | 27.12.2021 | ||
IE | 16.03.2022 | ||
LU | 16.03.2022 | ||
CH | 31.03.2022 | ||
LI | 31.03.2022 | ||
Former [2023/08] | AL | 25.08.2021 | |
AT | 25.08.2021 | ||
CZ | 25.08.2021 | ||
DK | 25.08.2021 | ||
EE | 25.08.2021 | ||
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
HR | 25.08.2021 | ||
IT | 25.08.2021 | ||
LT | 25.08.2021 | ||
LV | 25.08.2021 | ||
MC | 25.08.2021 | ||
NL | 25.08.2021 | ||
PL | 25.08.2021 | ||
RO | 25.08.2021 | ||
RS | 25.08.2021 | ||
SE | 25.08.2021 | ||
SI | 25.08.2021 | ||
SK | 25.08.2021 | ||
SM | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
GR | 26.11.2021 | ||
IS | 25.12.2021 | ||
PT | 27.12.2021 | ||
IE | 16.03.2022 | ||
LU | 16.03.2022 | ||
Former [2022/47] | AL | 25.08.2021 | |
AT | 25.08.2021 | ||
CZ | 25.08.2021 | ||
DK | 25.08.2021 | ||
EE | 25.08.2021 | ||
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
HR | 25.08.2021 | ||
IT | 25.08.2021 | ||
LT | 25.08.2021 | ||
LV | 25.08.2021 | ||
MC | 25.08.2021 | ||
NL | 25.08.2021 | ||
PL | 25.08.2021 | ||
RO | 25.08.2021 | ||
RS | 25.08.2021 | ||
SE | 25.08.2021 | ||
SI | 25.08.2021 | ||
SK | 25.08.2021 | ||
SM | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
GR | 26.11.2021 | ||
IS | 25.12.2021 | ||
PT | 27.12.2021 | ||
Former [2022/36] | AL | 25.08.2021 | |
AT | 25.08.2021 | ||
CZ | 25.08.2021 | ||
DK | 25.08.2021 | ||
EE | 25.08.2021 | ||
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
HR | 25.08.2021 | ||
IT | 25.08.2021 | ||
LT | 25.08.2021 | ||
LV | 25.08.2021 | ||
NL | 25.08.2021 | ||
PL | 25.08.2021 | ||
RO | 25.08.2021 | ||
RS | 25.08.2021 | ||
SE | 25.08.2021 | ||
SI | 25.08.2021 | ||
SK | 25.08.2021 | ||
SM | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
GR | 26.11.2021 | ||
IS | 25.12.2021 | ||
PT | 27.12.2021 | ||
Former [2022/29] | AL | 25.08.2021 | |
AT | 25.08.2021 | ||
CZ | 25.08.2021 | ||
DK | 25.08.2021 | ||
EE | 25.08.2021 | ||
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
HR | 25.08.2021 | ||
LT | 25.08.2021 | ||
LV | 25.08.2021 | ||
NL | 25.08.2021 | ||
PL | 25.08.2021 | ||
RO | 25.08.2021 | ||
RS | 25.08.2021 | ||
SE | 25.08.2021 | ||
SK | 25.08.2021 | ||
SM | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
GR | 26.11.2021 | ||
IS | 25.12.2021 | ||
PT | 27.12.2021 | ||
Former [2022/25] | AT | 25.08.2021 | |
CZ | 25.08.2021 | ||
DK | 25.08.2021 | ||
EE | 25.08.2021 | ||
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
HR | 25.08.2021 | ||
LT | 25.08.2021 | ||
LV | 25.08.2021 | ||
NL | 25.08.2021 | ||
PL | 25.08.2021 | ||
RO | 25.08.2021 | ||
RS | 25.08.2021 | ||
SE | 25.08.2021 | ||
SK | 25.08.2021 | ||
SM | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
GR | 26.11.2021 | ||
IS | 25.12.2021 | ||
PT | 27.12.2021 | ||
Former [2022/24] | AT | 25.08.2021 | |
CZ | 25.08.2021 | ||
DK | 25.08.2021 | ||
EE | 25.08.2021 | ||
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
HR | 25.08.2021 | ||
LT | 25.08.2021 | ||
LV | 25.08.2021 | ||
NL | 25.08.2021 | ||
PL | 25.08.2021 | ||
RO | 25.08.2021 | ||
RS | 25.08.2021 | ||
SE | 25.08.2021 | ||
SK | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
GR | 26.11.2021 | ||
IS | 25.12.2021 | ||
PT | 27.12.2021 | ||
Former [2022/21] | AT | 25.08.2021 | |
DK | 25.08.2021 | ||
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
HR | 25.08.2021 | ||
LT | 25.08.2021 | ||
LV | 25.08.2021 | ||
NL | 25.08.2021 | ||
PL | 25.08.2021 | ||
RS | 25.08.2021 | ||
SE | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
GR | 26.11.2021 | ||
IS | 25.12.2021 | ||
PT | 27.12.2021 | ||
Former [2022/16] | AT | 25.08.2021 | |
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
HR | 25.08.2021 | ||
LT | 25.08.2021 | ||
LV | 25.08.2021 | ||
NL | 25.08.2021 | ||
PL | 25.08.2021 | ||
RS | 25.08.2021 | ||
SE | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
GR | 26.11.2021 | ||
IS | 25.12.2021 | ||
PT | 27.12.2021 | ||
Former [2022/10] | AT | 25.08.2021 | |
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
HR | 25.08.2021 | ||
LT | 25.08.2021 | ||
LV | 25.08.2021 | ||
PL | 25.08.2021 | ||
RS | 25.08.2021 | ||
SE | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
GR | 26.11.2021 | ||
IS | 25.12.2021 | ||
PT | 27.12.2021 | ||
Former [2022/09] | AT | 25.08.2021 | |
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
LT | 25.08.2021 | ||
RS | 25.08.2021 | ||
SE | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
PT | 27.12.2021 | ||
Former [2022/08] | AT | 25.08.2021 | |
ES | 25.08.2021 | ||
FI | 25.08.2021 | ||
LT | 25.08.2021 | ||
SE | 25.08.2021 | ||
BG | 25.11.2021 | ||
NO | 25.11.2021 | ||
Former [2022/07] | AT | 25.08.2021 | |
LT | 25.08.2021 | ||
NO | 25.11.2021 | Cited in | International search | [A]WO8303830 (GRAY CHARLES RICHARDSON WHITE, et al) [A] 8,9* the whole document *; | [X]WO0018965 (UNIV UTAH RES FOUND [US]) [X] 8-11,16 * page 29, line 28 - line 32; example 2 *; | [XYI]CN102286473 (W WANG) [X] 1,2,16-18 * page 7, paragraph 61 - paragraph 62; claim 8 * [Y] 12-15 [I] 7,19,20; | [XDYI]US2012258500 (CHENG MAN [US]) [XD] 3,4,7,16 * paragraphs [0145] , [ 157] - [0158] * * paragraph [0096]; example 1; claim 1 * [Y] 27-29 [I] 5,6,17,18,22-26,30; | [I] - BU YING ET AL, "Direct polymerase chain reaction (PCR) from human whole blood and filter-paper-dried blood by using a PCR buffer with a higher pH", ANALYTICAL BIOCHEMISTRY, (20080101), vol. 375, doi:10.1016/j.ab.2008.01.010, pages 370 - 372, XP055001023 [I] 1,2,7,16-20 * page 371, column r, paragraph 2 - paragraph 3 * DOI: http://dx.doi.org/10.1016/j.ab.2008.01.010 | [Y] - ZELDIS J B ET AL, "DIRECT METHOD FOR DETECTING SMALL QUANTITIES OF HEPATITIS B VIRUS DNA IN SERUM AND PLASMA USING THE POLYMERASE CHAIN REACTION", JOURNAL OF CLINICAL INVESTIGATION, AMERICAN SOCIETY FOR CLINICAL INVESTIGATION, US, (19891101), vol. 84, no. 5, doi:10.1172/JCI114326, ISSN 0021-9738, pages 1503 - 1508, XP000616287 [Y] 12-15,27-29 * page 1506, column l, paragraph 1 * DOI: http://dx.doi.org/10.1172/JCI114326 | [A] - L. A. LYAPINA ET AL, "Anticoagulant Effects of a Complex of High Molecular Weight Heparin and Arginine", BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, US, (20090301), vol. 147, no. 3, doi:10.1007/s10517-009-0501-7, ISSN 0007-4888, pages 328 - 330, XP055476981 [A] 3,4,21 * the whole document * DOI: http://dx.doi.org/10.1007/s10517-009-0501-7 |